Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Day Lewis removes diabetes posters after patient complaints

Day Lewis has taken "immediate action" across all of its pharmacies after patients flagged a "misleading" diabetes poster.

Patients took to Twitter this week (June 14) to criticise the “misinformation” included in the pharmacy chain's diabetes posters.

The A3 poster – which was criticised for not distinguishing between type 1 and type 2 diabetes – had been put up across all Day Lewis branches during Diabetes Week 2017, to try to raise awareness about the condition.

Day Lewis told C+D today (June 16) it had “asked all pharmacies to remove the poster immediately” and had “apologised publicly for any confusion caused”.

“Following feedback from some patients through social media, we recognise that one of the A3 posters in our pharmacies may be interpreted in a different way than was originally intended.” For more of the response see below.

The complaints
The Day Lewis responses

In its statement to C+D, Day Lewis said as soon as it received the feedback, it had "felt it was necessary to take immediate action".

"Our pharmacy teams across the country have done a great job promoting diabetes awareness week to patients in the community. To date, our pharmacy teams have found the posters helpful during conversations with patients."

"We continue to listen to our patients, to help improve our service to them," Day Lewis added.

What are the common misunderstandings about diabetes?

Related Content

Topics

         
Pharmacy Manager
Guernsey
£70,000

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD008792

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel